Ambrx Biopharma Inc.

28.00
0.02 (0.07%)
At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-78M -68.29M -17.84M -22.31M
1.8M 2.15M 1.94M 2.05M
6.25M 11.86M 1.22M 1.83M
-9.65M -4.08M -1.28M 11.01M
11.89M 5.49M 1.48M 1.48M
n/a 513K n/a 11K
-10.62M 3.64M -7.38M 14.18M
-68.67M -44.64M -20.58M -2.77M
-1.05M -3.21M -252K -48K
45.66M n/a n/a n/a
-84.85M n/a n/a n/a
39.19M n/a n/a n/a
-45.66M n/a n/a n/a
-46.72M -3.21M -252K -48K
n/a n/a n/a n/a
n/a n/a n/a n/a
n/a n/a n/a n/a
928K 127.43M 95.68M n/a
928K 127.43M 95.68M n/a
-114.47M 79.63M 75.02M -2.85M
-69.73M -47.85M -20.83M -2.81M